Efficient tumor cell lysis by autologous, tumor-resident T lymphocytes in primary ovarian cancer samples by an EP-CAM-/CD3-bispecific antibody-Reference-Cited by-同舟云学术

Efficient tumor cell lysis by autologous, tumor-resident T lymphocytes in primary ovarian cancer samples by an EP-CAM-/CD3-bispecific antibody

Published:2003-03-05 Issue:2 Volume:105 Page:241-248
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Wimberger Pauline,Xiang Wei,Mayr Doris,Diebold Joachim,Dreier Torsten,Baeuerle Patrick A.,Kimmig Rainer

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ijc.11056/fullpdf

Reference46 articles.

1. Cancer statistics;Parker;CA Cancer J Clin.,1997

2. For the AGO Study Group: cisplatin/paclitaxel vs. carboplatin/paclitaxel as first-line treatment in ovarian cancer;du Bois;Proc Am Soc Clin Oncol,1998

3. Trastuzumab, a recombinant DNA-derived humanized monoclonal antibody, a novel agent for the treatment of metastatic breast cancer;Goldenberg;Clin Ther,1999

4. Targeting the epidermal growth factor receptor for cancer therapy;Mendelsohn;J Clin Oncol,2002

5. Inhibitory Fc receptors modulate in vivo cytotoxicity against their targets;Clynes;Nat Med,2000

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A tale of two specificities: bispecific antibodies for therapeutic and diagnostic applications;Trends in Biotechnology;2013-11

2. Bifunctional Antibodies: Preclinical and Clinical Applications;Advances in Tumor Immunology and Immunotherapy;2013-10-03

3. Cytotoxicity of cytokine-induced killer cells targeted by a bispecific antibody to gastric cancer cells;Oncology Letters;2013-04-02

4. The CEA/CD3-Bispecific Antibody MEDI-565 (MT111) Binds a Nonlinear Epitope in the Full-Length but Not a Short Splice Variant of CEA;PLoS ONE;2012-05-04

5. New Gene-Immunotherapy Combining TRAIL-Lymphocytes and EpCAMxCD3 Bispecific Antibody for Tumor Targeting;Clinical Cancer Research;2012-01-06